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Background and Objectives: Diabetes mellitus (DM), a risk factor of 
periodontal diseases, exacerbates the pathological condition of periodontitis.  
A major factor for DM complications is advanced glycation end-products 
(AGEs) that accumulate in periodontal tissues and cause inflammatory 
events.  Lipocalin 2 (LCN2) is an antimicrobial peptide and inflammation-
related factor, and LCN2 levels increase in DM.  In the present study, the 
effects of AGEs and lipopolysaccharide of Porphyromonas gingivalis (P.g-LPS) 
on LCN2 expression in human oral epithelial cells (TR146 cells) and the role 
of secreted LCN2 in periodontitis with DM were investigated.   
Material and Methods: TR146 cells were cultured with AGEs (AGE2) and 
control BSA and cell viability was estimated, or with P.g-LPS.  Conditioned 
medium and cell lysates were prepared from cultures of epithelial cells and 
used for western blotting and ELISA to analyze LCN2, RAGE, IL-6, MAPK 
and NF-kB.  RNA was isolated from AGE-treated TR146 cells and 
differentiated HL-60 (D-HL-60) cells and used for quantitative real-time PCR 
to examine the expression of LCN2 and interleukin-6 (IL-6) mRNAs.  RAGE- 
and LCN2-siRNAs (siRAGE, siLCN2) were transfected into epithelial cells, 
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and AGE-induced LCN2 expression was investigated.  D-HL-60 cells were 
co-cultured with TR146 cells that were transfected with siLCN2 and treated 
with AGEs, IL-6 mRNA expression in D-HL-60 cells and cell migration were 
investigated.   
Results: AGEs increased the expression levels of LCN2 and IL-6 in oral 
epithelial cells.  siRAGE and a neutralizing antibody for RAGE inhibited 
AGE-induced LCN2 expression.  AGEs stimulated the phosphorylation of 
ERK, p38 and NF-kB in epithelial cells, and their inhibitors suppressed AGE-
induced LCN2 expression.  In contrast, P.g-LPS did not show a significant 
increase on LCN2 level in TR146 cells that expressed toll-like receptor 2.  In 
co-culture experiments, AGE-induced LCN2 inhibited IL-6 mRNA expression 
in D-HL-60 cells, and LCN2 knockdown in epithelial cells suppressed HL-60 
cell migration. 
Conclusion: These results suggested that AGEs increase LCN2 expression via 
RAGE, MAPK, and NF-kB signaling pathways in oral epithelial cells, and 






1 | INTRODUCTION 
Diabetes mellitus (DM) is a metabolic disease involving hyperglycemia, and 
it causes complications including nephropathy, neuropathy, retinopathy, and 
periodontal diseases.1  DM patients have a high prevalence of periodontal 
diseases, and periodontitis in DM patients sometimes shows severe 
inflammation with multiple gingival abscesses and destruction of periodontal 
tissues and resorption of alveolar bone.2,3  Advanced glycation end-products 
(AGEs) are a major factor that cause DM complications and induce 
inflammatory responses in some systemic tissues.4,5  AGEs accumulate at 
greater levels in periodontal tissues of DM patients compared to non-DM 
individuals,6 and AGEs were observed in endothelial cells, epithelial cells, 
fibroblasts and inflammatory cells in periodontal tissues of DM-associated 
periodontitis.7  AGEs bound to the receptor of AGE (RAGE), and increased 
interleukin-6 (IL-6) expression and reactive oxygen species (ROS) activity, 
and they decreased type I collagen expression in gingival fibroblasts.8-10  The 
expression of vascular endothelial growth factor (VEGF) and inflammatory 
responses were induced by AGEs in human synoviocytes,11 and the secretion 
of IL-1b and TNF-a was increased by AGEs in human macrophages.12  
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Furthermore, AGEs inhibited osteoblastic cell differentiation, increased 
sclerostin expression in osteocytes, weakened bone structure, activated 
osteoclasts, and induced bone resorption.13-15  On the other hand, gingival 
epithelial cells express RAGE,16 and AGEs increased the expression of 
calprotectin (S100A8 and S100A9), which is an antimicrobial peptide and 
damage-associated molecular patterns in human gingival epithelial cell 
line.17  AGEs are thought to aggravate inflammation and tissue degradation 
by regulating the expression levels of inflammation-related factors in 
periodontal tissues, whereas AGEs are involved in the regulation of factors 
related to innate immunity.  However, there are few studies of AGEs in 
epithelial cells and their effect on oral epithelial cells is not well known. 
     Lipocalin 2 (LCN2), neutrophil gelatinase-associated lipocalin (NGAL), 
and 24p3, a secreted glycoprotein with a molecular weight of 24-25 kDa, are 
detected in organs including lung, breast, trachea prostate colon and kidney.18 
LCN2 is expressed in immune cells and epithelial cells, and LCN2 level 
increased in inflammatory bowel and skin diseases, kidney disorders and 
obesity.19-20  Serum LCN2 levels in DM patients with kidney diseases were 
higher than those of healthy individuals, and plasma LCN2 levels were 
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elevated in patients with gestational diabetes,22,23 suggesting that LCN2 is 
related to pathological conditions in DM.  LCN2 expression was increased by 
IL-1b in a human alveolar basal epithelial cell line, but IL-6, TNF-a and LPS 
did not show significant effects.24  In contrast, TNF-a and IFN-g induced 
LCN2 expression and secretion in cultured human and mouse adipocytes,25  
and LPS elevated LCN2 expression in retinal glial cells,26 and IL-6 and LPS 
stimulated LCN2 production in podocytes in kidney.27  Furthermore, 
glycated human albumin increased LCN2 expression in human aortic smooth 
muscle cells.28  Differential regulation of LCN2 production by several 
inflammation-related factors are reported in some cell species. 
LCN2 binds to a specific receptor called 24p3R,19,26,29 and shows 
multiple functions, including antimicrobial activity, modulating 
inflammation and cell growth/migration/invasion.19,20,21  For example, LCN2 
bound bacterial siderophores and inhibited bacterial growth by depletion of 
iron and showed an antibacterial action.30,31  LCN2 modulates inflammatory 
responses by inducing the expression of inflammation-related cytokines such 
as IL-6, IL-8 and TNF-a.32  In contrast, LCN2 expressed anti-inflammatory 
actions that suppressed LPS-induced expressions of TNF-a and IL-6 in 
7 
 
murine retinal cells.26  Furthermore, LCN2 induced chemotaxis of 
neutrophils,33,34 but knockdown of LCN2 promoted migration and its 
overexpression reduced the migration of colorectal cancer cells,35 and the 
over-expression of LCN2 was observed in more grown breast tumor, and a 
complex with LCN2 and matrix metalloproteinase-9 (MMP-9) influenced 
tumor growth and invasion.36  LCN2 plays complex roles in cell migration 
and proliferation.  Regarding periodontal diseases, LCN2 and MMP-9 were 
observed in polymorphonuclear leukocytes and connective tissues of adult 
and juvenile periodontitis,37 and LCN2 levels in periodontitis patients were 
significantly higher than those in healthy individuals.38  Although LCN2 
may influence inflammation in periodontal diseases, the exact role of LCN2 
in periodontitis is not well known. 
In the present study, to elucidate a role of LCN2 in DM-associated 
periodontitis, the effects of AGE and Porphyromonas gingivalis-lipopoly-
saccharides (P.g-LPS) on LCN2 expression were investigated in human oral 
epithelial cells, and the regulatory mechanisms of AGE-induced LCN2 




2 | MATERIAL AND METHODS 
2.1 | AGEs and reagents 
AGEs (AGE2) were prepared in accordance with a modified method of 
Okazaki et al..39  In brief, DL-glyceraldehyde (0.1 M; Sigma-Aldrich, St. Louis, 
MO, USA) and bovine serum albumin (BSA; 50 µg/ml; Sigma-Aldrich) were 
mixed in a sterile phosphate buffer (0.2 M, pH 7.4) containing penicillin (100 
U/ml) and streptomycin (100 µg/ml), and incubated on shaking at 37°C for 7 
days.  The mixture was dialyzed against phosphate-buffered saline (PBS; pH 
7.4) for 3 days.  Non-glycated BSA as a control was prepared from a mixture 
without glyceraldehyde in the same conditions.  The fluorescence of 
prepared AGE2 and non-glycated BSA solutions was determined at an 
excitation/emission wavelengths of 370/440 nm to assess AGE activity, and 
the fluorescence strength of AGE solution was 40-fold greater than that of 
non-glycated BSA. 
Ham’s F-12, Dulbecco’s modified Eagle’s medium (DMEM) and 
RPMI1640 media were obtained from FUJIFILM Wako Pure Chemical 
Corporation (Osaka, Japan).  Two P.g-LPS were purchased from InvivoGen 
(P.gingivalis LPS;TLR2 ligand, LPS-PG;TLR2/TLR4 ligand, San Diego, CA, 
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USA).   
  
2.2 | Cell cultures 
Human oral epithelial cells (TR146 cells) were kindly supplied by Dr. Mark 
Herzberg (Minnesota University).  Human gingival epithelial cells (Ca9-22 
cells) and HL-60 cells were obtained from the National Institutes of 
Biomedical Innovation, Health and Nutrition (Osaka, Japan).  TR146 cells 
were seeded at 5000 cells/cm2 and cultured in Ham’s F-12 supplemented with 
10% fetal bovine serum (FBS), penicillin and streptomycin for 5 days.  
Epithelial cells were cultured with 50 -1000 µg/ml AGEs or control BSA for 
24-72 h and then used for the cell viability assay and extraction of RNA and 
protein (cell lysate and conditioned medium).  Sub-confluent epithelial cells 
were treated with AGEs (500 µg/ml) or control BSA (500 µg/ml) for 15-60 min, 
and the cellular fraction was collected for western blotting of MAPK and NF-
kB phosphorylation.  In experiments with MAPK and NF-kB inhibitors, 
confluent cells were pre-cultured with SB203580 (15 µM), U0126 (10 µM), 
SP600125 (10 µM) or Bay11-7082 (10 µM) for 1 h and cultured with AGEs 
(500 µg/ml) or control BSA (500 µg/ml) for 48 h.  Conditioned medium was 
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used for LCN2 ELISA.  Ca9-22 cells were seeded at 1.5x104 cells/ml and 
cultured in Eagle’s Minimum Essential Medium (E-MEM) supplemented with 
10% FBS, penicillin and streptomycin for 4 days.  After reaching sub-
confluency, Ca9-22 cells were cultured with AGEs (500 µg/ml) or control BSA 
(500 µg/ml) for 24 h and 48 h, and total RNA was isolated from the treated 
cells for quantitative real-time polymerase chain reaction (qRT-PCR) and the 
conditioned medium was used for enzyme-linked immunosorbent assay 
(ELISA).  In an experiment with a neutralizing antibody, sub-confluent 
TR146 cells were pre-cultured with a neutralizing antibody against RAGE 
(1/20 dilution, GeneTex, Hsinchu City, Taiwan) for 2 h and then cultured with 
AGEs (500 µg/ml) or control BSA (500 µg/ml) for 48 h.  In the experiment 
using two P.g-LPSs, TR146 cells were cultured with P.g-LPS for TLR2 ligand 
(0.2-5 µg/ml), P.g-LPS for TLR2/TLR4 ligand (0.25-1 µg/ml), and AGEs (500 
µg/ml) or BSA (500 µg/ml) for 48 h.  The collected conditioned medium was 
used for LCN2 ELISA and the cell lysate was used for western blotting of 
RAGE and TLR2. 
HL-60 cells were seeded at 150x104 cells/ml in RPMI-1640 medium 
supplemented with 20% FBS and antibiotics and grown, and then cultured 
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with 1.25% dimethyl sulfoxide (DMSO; FUJIFILM Wako Pure Chemical 
Corp.) for 5 days to differentiate granulocyte-like cells according to a modified 
method of Manda-Handzlik et al..40 
                       
2.3 | Cell viability assay 
The effect of AGEs on the viability of TR146 cells was examined using a Cell 
Counting Kit-8 (CCK-8; Dojindo, Kumamoto, Japan) in accordance with the 
manufacturer’s instructions.  Briefly, epithelial cells were seeded at cell 
density of 5000 cells/cm2 on 96-well plates, and were cultured for 5 days and 
further cultured with AGEs (500 µg/ml) or control BSA (500 µg/ml) for 24-72 
h, and then incubated with CCK-8 solution for 2 h.  The absorbance of a well 
was measured at wavelength of 450 nm using a microplate reader.  
  
2.4 | RNA isolation and qRT-PCR 
Total RNAs were isolated from TR146 cells, Ca9-22 cells and HL-60 cells 
using a RNeasy Mini Kit (QIAGEN, Hilden, Germany).  Complementary 
DNAs were synthesized from total RNA using the DNase I Amplification 
Grade (Invitrogen, Life Technologies Corp./Thermo Fisher Scientific, 
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Carlsbad, CA, USA) and PrimerScript® II 1st strand cDNA Synthesis Kit 
(TaKaRa Bio., Otsu, Japan) in accordance with the manufacturer’s 
instructions.  In qRT-PCR, the PCR mixture contained a synthesized cDNA, 
primers of BD-2, IL-1b, IL-6, LCN2, RAGE, SLPI, TNF-a, and b-actin and 
SYBR Green (Sso Advanced Universal SYBR Green Supermix, Bio Rad).  
PCR reaction was performed at 95°C for 30 sec once, at 95°C 10 sec and 60°C 
30 sec for 40 cycles, and at 65°C for 5 sec and 95°C for 50 sec each once using 
a CFX96TM Real-time PCR Detection System (Bio-Rad).  The levels of mRNA 
expression were normalized to b-actin mRNA.  The sequences of the forward 
and reverse primers used in the present experiments were as follows: b-actin 
(ACTB); 5’-CGTCCACCGCAAATGCTT-3’ and 5’-GTTTTCTGCGCAAGT 
TAGGTTTTG-3’, BD-2(DEFB4A); 5’-GGTGTTTTTGGTGGTATA GGCG-3’ 
and 5’-AGGGCAAAAGACTGGATGACA-3’, IL1B; 5’-ACAGATGAAGTGCTC 
CTTCCA-3’ and 5’-GTCGGAGATTCGTAGCTGGAT-3’, IL6; 5’-AGGGCTCTT 
CGGCAAATGT-3’ and 5’-GAAGAAGGAATGCCCATTAAC AAC-3’, LCN2; 5’-
CCACCTCAGACCTGATCCCA-3’ and 5’-CCCCTGGAATTG GTTGTCCTG-3’, 
RAGE; 5’-TCCAGGATGAGGGGATTTTC-3’ and 5’-CCAAGTGCCAGCTAA 
GAGTC-3’, SLPI; 5’-GCATCAAATGCCTGGATCCT-3’ and 5’-GCATCAAAC 
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ATTGGCCATAAGTC-3’, TNFA; 5’-TCAATCGGCCCG ACTATCTC-3’ and 5’-
ACAGGGCAATGATCC CAAAGT. 
 
2.5 | ELISA 
Sub-confluent TR146 cells were cultured with AGEs or control BSA at 
concentrations of 50-1000 µg/ml for 24-72 h.  In experiments using Pg.-LPS, 
oral epithelial cells were treated with P.g-LPS (1 µg/ml) in the presence or 
absence of AGEs (500 µg/ml) or BSA (500 µg/ml) for 48 h.  In co-culture 
experiments, AGE-stimulated TR146 cells and differentiated HL-60 (D-HL-
60) cells were co-cultured for 24 h.  After each culture, the conditioned 
medium was collected and mixed with phenylmethylsulfonyl fluoride (PMSF, 
Sigma-Aldrich).  LCN2 and IL-6 in the conditioned medium were 
determined using a Human Lipocalin-2/NGAL Immunoassay (R&D Systems, 
Minneapolis, MN, USA) and a Human IL-6 Immunoassay (R&D Systems), 
respectively, in accordance with each manufacturer’s instructions.      
 
2.6 | Western blotting 
Oral epithelial cells at sub-confluency were cultured with AGEs (500 µg/ml) 
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or control BSA (500 µg/ml) for 48 h, and cellular fractions were collected.  In 
experiments with MAPK and NF-kB phosphorylation, cells were treated with 
AGEs (500 µg/ml) or BSA (500 µg/ml) for 15-60 min, and cell samples were 
isolated.  The cellular fractions were dissolved in RIPA Lysis Buffer 
containing protease inhibitor cocktail and sodium orthovanadate (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), and incubated on ice for 15 min and 
centrifuged at 10,000xg at 4°C for 10 min.  The supernatant was used for 
western blotting analysis.  Total protein in the supernatant was determined 
using a BCA Protein Assay Kit (TaKaRa Bio.).  The proteins (2.5-12.5 µg) 
were electrophoretically separated on SDS-polyacrylamide gel (10%) and 
transferred to a polyvinylidene difluoride membrane (Immobilon®-P, Merck 
Millipore Ltd., Carrigtwohill, Co. Cork, ILR).  The membranes were blocked 
using PVDF Blocking Reagent for CanGet Signal® (TOYOBO, Osaka, Japan) 
at room temperature for 1 h and washed in Tris-buffered saline-Tween 20 
three times.  The blocking membranes were reacted with an anti-RAGE 
antibody (1/200 dilution, Abcam, Cambridge, MA, USA), anti-p38 and anti-
phospho-p38 (1/1000 dilution, Cell Signaling Technology, Danvers, MA, USA), 
anti-p44/42 (ERK) and anti-phospho-ERK (1/1000 dilution, Cell Signaling 
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Technology), anti-SAPK/JNK (JNK) and anti-phospho-JNK (1/1000 dilution, 
Cell Signaling Technology,), and anti-NF-kB p65 and anti-phospho-NF-kB 
p65 (1/1000 dilution, Cell Signaling Technology) in CanGet Signal solution 1 
(TOYOBO) at 4°C overnight.  After washing, the membranes were reacted 
with horseradish peroxidase (HRP)-conjugated anti-rabbit IgG (Cell 
Signaling) at room temperature for 1 h.  The membrane was treated with 
stripping buffer, blocked, and reacted with anti-b-actin antibody at room 
temperature for 1 h and then with HRP-conjugated secondary antibody.  The 
membranes reacted with antibodies were developed using ECLTM Western 
Blotting Detection Reagents (GE Healthcare) and visualized using Image 
Quant LAS 500 (GE Healthcare).  To detect TLR2 in TR146 cells treated 
with P.g-LPS and 24p3R in D-HL-60 cells, the cellular fraction was isolated 
from each cell lysate.  In contrast, conditioned media were collected from the 
cultures of TR146 cells and D-HL-60 cells to detect LCN2.  These fractions 
were separated by SDS-PAGE, and the cellular protein (10-20 µg total 
protein) and medium fraction (10 µl) on gels were transferred to PVDF 
membrane and reacted with anti-TLR2 antibody (1/2000 dilution, GeneTex), 
anti-LCN2 antibody (1/1000 dilution, LSBio, TE Huissen, The Netherlands) 
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or anti-BOCT (lipocalin 2 receptor; 24p3R) antibody (1/1000 dilution, St 
John’s Laboratory Ltd., London, UK) at room temperature for 2-3 h, and then 
reacted with HRP-conjugated anti-rabbit polyclonal antibody (1/15000 
dilution, GeneTex) at room temperature for 1 h.  After washing, the 
membranes were developed by ECLTM Western Blotting Detection Reagents 
(GE Healthcare), and the reactive signals were visualized using Image Quant 
LAS 500 (GE Healthcare) and analyzed using Image J software (NIH, USA).   
 
2.7 | siRNA transfection and co-culture with TR146 and D-HL-60 cells 
TR146 cells were seeded at 5.4x104 cells/cm2 and cultured in Ham’s F-12 
medium with 10% FBS for 24 h and reached to 70% confluency, and 
transfected with RAGE siRNA (siRAGE, 6.25 nM; Sigma-Aldrich/Merck 
KGaA, Darmstadt, Germany) and Control siRNA (siControl, 6.25 nM) 
dissolved in Opti-MEM medium (Thermo Fisher SCIENTIFIC, Waltham, MA, 
USA) using Lipofectamine RNAiMax (Thermo Fisher SCIENTIFIC) in 
accordance with the manufacturer’s instructions.  Cells were further 
cultured with AGEs (500 µg/ml) or control BSA (500 µg/ml) for 24 h to isolate 
RNA and for 48 h to collect conditioned medium.  RNA from the transfected 
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cells was used for qRT-PCR and the conditioned medium was for ELISA in 
order to investigate the expression levels of RAGE and LCN2. 
     In co-culture experiments with TR146 cells and HL-60 cells, epithelial 
cells (8x104 cells /cm2) were seeded into the outer-well of Transwell® 
Permeable Supports (Corning, Kennebunk, ME, USA) and cultured in Ham’s 
F-12 supplemented with 10% FBS for 24 h, and then transfected with LCN2 
siRNA (siLCN2, 6.25 nM; Sigma-Aldrich/Merck) and siControl (6.25 nM) 
using Lipofectamine RNAiMax (Thermo Fisher SCIENTIFIC).  The 
transfected TR146 cells were cultured with AGEs (500 µg/ml) or BSA (500 
µg/ml) for 48 h, and washed with PBS (pH 7.4) to remove AGEs and BSA.  D-
HL-60 cells (350x104 cells/ml) were seeded in the inserts of Transwell® 
Permeable Supports (3 µm polycarbonate membrane, Corning) and co-
cultured with TR146 cells that were transfected with siLCN2 in AGE-free 
medium (RPMI1640 and Ham’s F-12 medium) with 10% FBS for 24 h.  Total 
RNA was isolated from TR146 cells and D-HL-60 cells, and used for qRT-PCR 
to examine the expression levels of LCN2 and IL6 mRNAs, respectively.  The 
conditioned medium was collected from the co-culture system and used for 




2.8 | Cell migration assay 
D-HL-60 cells (350x104 cells/ml) and TR146 cells transfected with siLCN2 or 
siControl, and treated with AGEs (500 µg/ml) or BSA (500 µg/ml) were co-
cultured for 24 h using Transwell® plates (3 µm pore size-polycarbonate 
membrane, Corning), and the migration of D-HL-60 cells was assayed in  
accordance with the modified method of Justus et al..41  Briefly, D-HL-60 
cells were removed from Transwell inserts after co-culture of D-HL-60 cells 
and TR146 cells, and an insert membrane was carefully washed in PBS, 
dipped in 70% ethanol solution to fix D-HL-60 cells that migrated to the 
undersurface of the Transwell insert for 10 min.  The membrane of the 
Transwell insert was dried for 30 min and stained in 0.2% crystal violet 
solution for 10 min at room temperature.  After remove excessive staining 
solution, the membrane with migrated HL-60 cells was very carefully dipped 
into distilled water many times, and dried for over 30 min.  The cells 
migrated to an undersurface of Transwell insert were observed using a phase-
contrast microscope (magnification x 100), and the number of migrated cells 
was counted in four microscopic field of three separated insert membranes in 
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each experimental group. 
 
2.9 | Statistical analysis 
The number of samples in all experiments was more than four (n=4-10).  
Statistical analyses were performed using Excel Analysis 2012 for Windows 
(SSRI, Tokyo, Japan).  The comparisons among multiple groups were 
performed by a one-way analysis of variance (ANOVA) followed by Tukey-
Kramer analysis, and the significance of differences between two groups was 
estimated using Student’s t-test.  P values less than 0.05 were considered to 
be significant. 
 
3 | RESULTS 
3.1 | Effect of AGEs on cell viability of TR146 cells 
The viability of TR146 cells was not significantly changed when epithelial 
cells were cultured with AGEs (500 µg/ml) for 72 h (Supplementary figure 1).  
Their percentages were 100% at 24 h, 92.3% at 36 h, 92.1% at 48 h, and 85.1% 
at 72 h.  Significant differences in cell viability between the AGE and control 




3.2 | Effects of AGEs on the expression of LCN2 and IL-6 in TR146 cells 
AGE treatment significantly increased the expression of LCN2 mRNA to 
approximately 1.8-fold that of control BSA when TR146 cells were stimulated 
by AGEs (500 µg/ml) for 24 h (Figure 1A).  IL6 mRNA expression was also 
increased by AGEs (500 µg/ml) approximately 2-fold in TR146 cells (Figure 
1B).  AGEs (500 µg/ml) increased LCN2 mRNA expression by approximately 
1.8-fold in Ca9-22 human gingival epithelial cells (Figure 1C).  In contrast, 
the expression levels of BD-2 (b-defensin 2) and SLPI, other antimicrobial 
peptides, were not influenced by AGEs in TR146 cells (Supplementary Figure 
2A and 2B). 
 
3.3 | Effects of AGEs on the production of LCN2 and IL-6 in TR146 cells 
LCN2 production was significantly increased on 48-72 h when TR146 cells 
were cultured with AGEs (500 µg/ml) for 24-72 h, and its level was 
approximately 1.8-fold that of control BSA at 48 h, and 1.9-fold at 72 h (Figure 
2A).  When epithelial cells were stimulated by 50-1000 µg/ml AGEs for 48 h, 
AGEs significantly increased LCN2 production at concentrations of 100-500 
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µg/ml, and the elevated LCN2 level reached approximately 1.6-fold of that of 
control with 500 µg/ml AGEs (Figure 2B).  AGEs (500 µg/ml) significantly 
increased the productions of IL-6 as well as LCN2 in TR146 cells (Figure 2C), 
and similarly up-regulated LCN2 production in Ca9-22 cells; however, the 
level of LCN2 concentration in Ca9-22 cells was low, approximately 5% of its 
level in TR146 cells (Figure 2D). 
 
3.4 | Inhibitory effect of siRAGE and neutralizing antibody on AGE-induced 
LCN2 expression 
TR146 cells expressed RAGE, but its level was not changed by AGE 
stimulation (Figure 3A).  When RAGE siRNA was transfected into TR146 
cells, the expression of RAGE mRNA in epithelial cells was significantly 
inhibited (Figure 3B).  RAGE siRNA significantly inhibited AGE-induced 
LCN2 mRNA expression and its protein production to similar level by BSA 
induction (Figure 3C, 3D).  Furthermore, anti-RAGE neutralizing antibody 
significantly inhibited AGE-stimulated LCN2 production (Figure 3E). 
 
3.5 | Involvements of MAPK and NF-kB in AGE-induced LCN2 expression 
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To investigate the involvement of MAPK in AGE-stimulated LCN2 expression, 
western blotting analyses of MAPK phosphorylation were performed.  The 
phosphorylation of ERK and p38 was increased by AGE stimulation for 15 or 
60 min, respectively, however AGEs did not influence JNK phosphorylation 
(Figure 4A).  When epithelial cells were cultured with AGEs after pre-
treatment with MAPK inhibitors, AGE-induced LCN2 production was 
significantly inhibited by p38 inhibitor (SB203580) and ERK inhibitor 
(U0126), but not by JNK inhibitor (SP600125) (Figure 4B).  With regard to 
NF-kB, AGEs stimulated NF-kB phosphorylation compared with control BSA 
(Figure 4C), and NF-kB inhibitor (Bay11-7082) significantly decreased AGE-
induced LCN2 production (Figure 4D). 
 
3.6 | Effect of AGEs and P.g-LPS on LCN2 production in TR146 cells 
TR146 cells expressed TLR2, however, its level was not changed by 
stimulation with P.g-LPS, with or without AGEs or BSA (Figure 5A).  When 
TR146 cells were cultured with P.g-LPS as a TLR2 ligand at concentrations 
of 0.2-5 µg/ml and P.g-LPS as a TLR2/TLR4 ligand at concentrations of 0.25-
1 mg/ml for 48 h, two P.g-LPSs did not show a significant change in LCN2 
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production (Supplementary Figure 3A and 3B).  Furthermore, LCN2 
production in epithelial cells stimulated with P.g-LPS as a TLR2 ligand (1 
µg/ml) and AGEs (500 µg/ml) was not increased more than that with AGE 
stimulation (Figure 5B).   
 
3.7 | Effect of AGE-induced LCN2 from TR146 cells on IL-6 expression in D- 
HL-60 cells 
TR146 cells secreted LCN2 into the cultured medium, but D-HL-60 cells did 
not (Figure 6A).  The signals of 24p3R-long and -short type expressed in D-
HL-60 cells, but both types of LCN2 receptor were not expressed in TR146 
cells (Figure 6A).  The expression levels of LCN2 mRNA were significantly 
inhibited in TR146 cells transfected with siLCN2 and then stimulated with 
AGEs and BSA (Figure 6B).  LCN2 secretion was significantly increased by 
AGE treatment in TR146 cells transfected with siControl and siLCN2, and 
AGE- and BSA-induced LCN2 secretion was significantly decreased by LCN2 
mRNA knockdown in a similar manner to a change in LCN2 mRNA (Figure 
6C).  When D-HL-60 cells were co-cultured with TR146 cells transfected with 
siLCN2 or siControl, the level of IL6 mRNA expression in D-HL-60 cells in 
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the siLCN2 group was significantly higher than that in the siControl group 
(Figure 6D).  IL6 mRNA expression in HL-60 cells, which were co-cultured 
with AGE-stimulated TR146 cells, was significantly reduced as compared 
with BSA-treated TR146 cells in both groups with siControl and siLCN2.   
Furthermore, IL-6 protein levels in the conditioned medium from the co-
culture with TR146 cells transfected with siLCN2 and D-HL-60 cells also was 
higher than that in siControl group (Supplementary figure 4).  These results 
suggested that LCN2 from epithelial cells suppressed IL-6 expression in 
neutrophils and AGEs promoted this down-regulation of IL-6 expression 
through the LCN2 pathway.  In contrast, IL1B mRNA expression in D-HL-
60 cells co-cultured with siLCN2-transfected and BSA-treated TR146 cells 
slightly increased compared with that of siControl-transfected TR146 cells, 
but IL1B mRNA expression in the AGE-treatment group did not significantly 
change between siLCN2 and siControl (Supplementary figure 5A).  In 
addition, there were no differences in TNFA mRNA expression in D-HL-60 
cells between siLCN2 and siControl, and between AGEs and BSA 




3.8 | Effect of AGE-induced LCN2 from TR146 cells on the migration of D-
HL-60 cells 
The migration of D-HL-60 cells co-cultured with TR146 cells transfected with 
siLCN2 was significantly inhibited as compared with that of siControl in 
BSA- and AGE-treated TR146 cell groups (Figure 7).  When D-HL-60 cells 
were co-cultured with AGE-treated TR146 cells that was transfected with 
siControl, the migration of D-HL-60 cells significantly increased as compared 
with BSA-treated TR146 cells, but an AGE-induced increase was not observed 
in the group with TR146 cells transfected with siLCN2 (Figure 7E).  The 
results in Figure 6C and 7E suggested that LCN2 from epithelial cells 
enhanced the migration of neutrophils. 
   
4 | DISCUSSION 
LCN2 is expressed in some cells including neutrophils, macrophages, several 
epithelial cells, adipocytes and kidney cells, and LCN2 expression increased 
in several inflammatory diseases including psoriasis, periodontitis and 
ulcerative colitis.19,20,21  LCN2 (NGAL) was detected in polymorphonuclear 
leukocytes infiltrated into gingival connective tissues with periodontitis,37 
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and LCN2 levels in gingival crevicular fluid samples from the site with 
periodontitis were higher than that of healthy samples.38  We previously 
showed that primary human gingival epithelial cells expressed LCN2 mRNA 
and produced LCN2 protein,42 and that oral epithelial cells (TR146 cells) and 
gingival epithelial cells (Ca9-22 cells) also produced and secreted LCN2 in the 
present study.  These reports suggested that LCN2 that is derived from cells 
in oral and periodontal tissues is related to periodontitis. 
    LCN2 levels in serum and plasma from patients with type 2 DM were 
significantly higher than that in healthy individuals.22,43  LCN2 may 
influence the pathological condition of DM, but details of the function and 
mechanism are still being investigating.  Chung et al.28 first reported that 
AGEs, a major factor caused DM complications, increased LCN2 levels in 
human vascular smooth muscle cells and stimulated invasion and migration 
of cells by up-regulation of LCN2 expression.  AGEs increased the 
expressions of IL-6 and ICAM-1 in human gingival fibroblasts,9 and the 
expressions of IL-6 and LCN2 in oral and gingival epithelial cells, suggesting 
AGEs influence several cells in periodontal tissues and aggravate 
inflammation by regulating the expression of inflammation-related factors. 
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     Although AGEs and IL-1a increased LCN2 levels in human oral and 
gingival epithelial cells,42 the effects of pro-inflammatory cytokines (IL-1b, IL-
6 and TNF-a) and E.coli-LPS on LCN2 expression appear to be different 
according to the cell species,24-27 and their regulation of LCN2 expression is 
thought to be dependent on the expression of specific receptors and co-factors 
in various cells.19  In the present study, although TR146 cells expressed 
TLR2 and TLR4, and the used two P.g-LPSs bound to TLR2 and TLR2/TLR4 
did not significantly increased LCN2 expression in epithelial cells.  Bondy-
Carey et al.44 showed that P.gingivalis did not affect the expression levels of 
LCN2, IL-1b and IL-8 in primary human gingival epithelial cells, but the 
levels of three factors increased remarkably when P.gingivalis was added to 
the co-culture with epithelial cells and primary human neutrophils, 
suggesting that P.gingivalis mainly increases LCN2 expression in the 
presence of neutrophils.  LCN2 may be produced in AGE-stimulated 
epithelial cells and P.gingivalis-stimulated neutrophils in periodontal tissues 
of periodontitis with DM, and may influence inflammation in DM-associated 
periodontitis. 
     The signaling pathway in AGE-induced LCN2 expression is still not well 
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understood.  In the present study, oral and gingival epithelial cells (TR146 
and Ca9-22) expressed RAGE mRNA or its protein, but AGEs did not show a 
clear change in RAGE level, suggesting that the change in RAGE expression 
in response to AGEs may be different depending on the cell species.  In any 
case, AGEs increased LCN2 expression through the RAGE pathway because 
RAGE siRNA and anti-RAGE neutralizing antibody significantly inhibited 
AGE-induced LCN2 expression in oral epithelial cells. 
     In a case of oral epithelial cells (TR146 cells), AGEs stimulated the 
phosphorylation of ERK and p38 and their specific inhibitors significantly 
inhibited AGE-induced LCN2 expression in oral epithelial cells (TR146 cells).  
In human aortic smooth muscle cells, AGEs increased the phosphorylation of 
Akt, ERK, JNK and p38, however ERK and p38 inhibitors did not 
significantly decrease LCN2 expression.28  NF-kB was related to the 
regulatory mechanism of AGE-induced LCN2 expression in TR146 cells in the 
present study.  The promoter region of human lipocalin 2 gene contained 
response elements for several transcription factors including NF-kB, AP-1 
and C/EBPb.19,28,45  Bu et al.46 showed that LCN2 expression increased in an 
NF-kB-dependent manner when human vascular smooth muscle cells were 
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stimulated with IL-1b.  In contrast, Chung et al.28 reported that C/EBPb, but 
not NF-kB, was the transcription factor responsible in AGE-induced LCN2 
expression in vascular smooth muscle cells.  The contribution of C/EBPb to 
AGE-induced LCN2 expression in oral epithelial cells was not elucidated, 
however, NF-kB is thought to be closely associated with AGE-induced LCN2 
expression, and we speculated that the MAPKs and transcription factors 
related to AGE-induced LCN2 expression may be different in various cell 
types. 
     LCN2 has multiple functions including the fields of infection, immunity, 
inflammation and metabolism, and plays roles as an inflammatory mediator 
and anti-inflammatory regulator.20  LCN2 secreted from oral epithelial cells 
suppressed IL-6 expression in neutrophils in the present study (Figure 6), and  
recombinant LCN2 (25 nM) decreased LPS-induced IL6 mRNA expression in 
LCN2-deficient bone marrow-derived macrophages.47  The levels of pro-
inflammatory cytokines such as IL-6, TNF-a and MCP-1 elevated in retina 
tissue with LPS-induced uveitis, and an injection of LCN2 into the retina 
reduced the increases in these cytokine levels and inflammatory infiltration, 
and LCN2 (40 nM) further suppressed LPS-induced TNF-a and IL-6 
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expressions in retinal cell of neonatal rats.26  These results showed anti-
inflammatory functions by LCN2.  In contrast, when human neutrophils and 
differentiated HL-60 cells were stimulated with recombinant lipocalin 
(rLCN2) at 500 nM and 1 µM, the expression levels of pro-inflammatory 
cytokines such as IL-6, IL-8 and TNF-a were significantly increased.33  
LCN2 (10 µM) purified from mouse uterine fluid elevated the levels of IL-6, 
IL-8 and MCP-1 in conditioned medium from a human endometrial cell line.48  
These reports suggested that LCN2 induced inflammatory responses, and 
LCN2 appears to play complex roles with regard to inflammation.  We 
speculated that this difference of LCN2 function may be due to the 
concentration of LCN2.  When LCN2 at comparatively high concentrations 
(more than 500 nM) was used, LCN2 up-regulated inflammatory 
responses,33,48 but anti-inflammatory effects were induced by LCN2 at lower 
concentrations (25 and 40 nM).26,47  In the present experiment of Figure 6C,  
LCN2 concentrations in the co-culture medium of the siLCN2 group was 
approximately 0.4-0.8 nM, and IL-6 expression levels in D-HL-60 cells 
significantly elevated in these culture conditions (Figure 6D).  Furthermore, 
LCN2 concentrations in GCF were in the range of 2.4 to 4.4 nM and serum 
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LCN2 concentration was approximately 2.4-10 nM.22,38  LCN2 at 
physiological concentrations in the body may play a role as an anti-
inflammatory regulator because LCN2 concentrations in body fluid appear to 
be comparatively low.  However, the pathophysiological functions of LCN2 
for inflammatory responses have not been decided because LCN2 
concentrations were not measured in local periodontal tissues with 
periodontitis. 
     In the present study, when differentiated HL-60 cells were co-cultured 
with TR146 cells that were transfected with siControl and stimulated with 
AGEs, the migration of D-HL-60 cells was promoted.  D-HL-60 cell 
migration was significantly inhibited by a co-culture with TR146 cells with 
LCN2 knockdown by siLCN2 transfection.  LCN2 is known to be implicated 
in cell proliferation, migration and chemotaxis of immune cells and cancer 
cells.49  Schroll et al.34 showed that recombinant human LCN2 at a 
concentration of 10 nM stimulated chemotaxis of polymorphonuclear 
neutrophils (PMNs), and chemotactic activity of PMNs isolated from LCN2 
knockout mice reduced, and Shao et al.33 reported that recombinant mouse 
LCN2 (20 nM) induced chemotaxis of peripheral neutrophils from psoriatic 
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patients, suggesting that LCN2 at lower concentrations (10-20 nM) 
stimulated the chemotactic activity of neutrophils and was considered to 
promote the infiltration of neutrophils into inflammatory tissues. 
     There are very few reports that have investigated the effect of AGEs on 
cell migration via LCN2 action.  Chung et al.28 demonstrated that AGE-
elicited LCN2 promoted the migration of vascular smooth muscle cells and 
influenced diabetic vascular complications.  We firstly found that LCN2 from 
AGE-stimulated oral epithelial cells promoted the migration of neutrophils 
and affected the expression of pro-inflammatory cytokines in neutrophils.  
LCN2 appears to regulate complex inflammatory and anti-inflammatory 
responses in various tissues.  In the present study, LCN2 stimulated the 
migration of neutrophils, whereas it suppressed IL-6 expression in 
neutrophils.  Although the pathophysiological functions of LCN2 are still not 
fully elucidated, the present study suggests that AGEs increased LCN2 
expression in oral epithelial cells via the RAGE, MAPKs (ERK and p38) and 
NF-kB signal pathway, and secreted LCN2 may function as a modulator of 
inflammation and a regulator of the immune system by anti-inflammatory 
actions (Figure 8).  Taken together, AGE-induced LCN2 from epithelial cells 
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acts directly in pathological conditions such as periodontitis with DM and 
shows indirect influences by regulating the functions of neutrophils. 
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SUPPORTING MATERIAL 
Supplementary figure 1. Effect of AGEs on the cell viability of TR146 cells. 
 
Supplementary figure 2. Effect of AGEs on b-defensin 2 and SLPI expression 
in TR146 cells. 
 
Supplementary figure 3. Effect of P.g-LPS on LCN2 expression in TR146 cells. 
 
Supplementary figure 4. Effect of LCN2 from TR146 cells on IL-6 protein 
secretion into the conditioned medium of the co-culture system with TR146 
and D-HL-60 cells. 
 
Supplementary figure 5. Effect of AGE-induced LCN2 from TR146 cells on IL-





Figure 1.  Effects of AGEs on the expressions of LCN2 and IL6 mRNAs in 
oral and gingival epithelial cells.  Total RNAs were extracted from TR146 
cells (A, B) and Ca9-22 cells (C) cultured with AGEs or BSA, and analyzed by 
qRT-PCR.  The expression levels of LCN2 and IL6 were normalized to that 
of ACTB.  Data for LCN2 and IL6 in TR146 cells are expressed as the mean 
± SD of eight and six RNA samples, respectively.  LCN2 data from Ca9-22 
cells are the mean ± SD of five RNA samples.  **P<0.01 compared with BSA. 
 
Figure 2.  Effects of AGEs on the expression levels of LCN2 and IL-6.  The 
amounts of LCN2 and IL-6 in the conditioned medium from TR146 cells that 
were cultured with AGEs (50-1000 µg/ml; closed column) and BSA (0-1000 
µg/ml; open column) for 24-72 h were using each ELISA kit (A, B, C).  Data 
are expressed as the mean ± SD of three-seven samples in (A), four-ten 
samples in (B) and three samples in (C).  (D) LCN2 amount in the 
conditioned medium of Ca9-22 cells cultured with AGEs (500 µg/ml) or BSA 
(500 µg/ml) for 48 h was determined.  Data are expressed as the mean ± SD 




Figure 3.  Regulation of AGE-induced LCN2 expression by inhibiting RAGE 
expression.  (A) RAGE protein in the cell lysates from TR146 cells cultured 
with AGEs (500 µg/ml) or BSA (500 µg/ml) for 48 h was analyzed by western 
blotting.  Four separate samples were analyzed, and a typical example is 
shown.  (B, C, D) TR146 cells transfected with siRAGE or siControl were 
cultured with AGEs or BSA for 24 h (RNA assay) or 48 h (protein assay) as 
described in Materials and Methods.  Data of RAGE and LCN2 mRNAs, and 
LCN2 protein in the conditioned medium are expressed as the means ± SD of 
six-ten samples (B, C) and four-six samples (D), respectively.  (E) In an 
experiment using a neutralizing antibody against RAGE, data of LCN2 
amount are expressed as the mean ± SD of four-six samples.  *P<0.05, 
**P<0.01 comparing between BSA and AGEs in the siControl group, and 
comparing BSA and AGEs between siControl and siRAGE. 
 
Figure 4.  Involvement of MAPKs and NF-kB in AGE-induced LCN2 
expression in TR146 cells.  (A, C) Cell lysate samples were prepared from 
TR146 cells that were treated with AGEs or BSA for 15 or 60 min.  The 
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phosphorylation levels of p38, ERK, JNK and p65 were examined by western 
blot analysis as described in Materials and Methods.  In total, four-six 
samples were analyzed and a typical image is shown for each.  The numbers 
in parentheses are ratios of image density determined using Image J and 
normalized to the Control image.  (B, D) In experiments using inhibitors 
including SB203580 (15 µM), U0126 (10 µM), SP600125 (10 µM) and Bay11-
7082 (10 µM), LCN2 amount in the conditioned medium from TR146 cells 
treated with AGEs or BSA was determined using a LCN2 ELISA kit.  Data 
are expressed as the mean ± SD of nine-fifteen samples.  **P<0.01 
comparing between BSA and AGEs. 
  
Figure 5.  Effect of P.g-LPS and AGEs on LCN2 expression in TR146 cells.  
(A) The cell lysate was collected from TR146 cells that were incubated with 
P.g-LPS (1 µg/ml), AGEs (500 µg/ml) or BSA (500 µg/ml) for 48 h.  TLR2 in 
the cell lysate samples was analyzed by western blotting.  Three separate 
samples were analyzed, and a typical example is shown.  (B) LCN2 protein 
in the conditioned medium from TR146 cells that were cultured with P.g-LPS, 
AGEs or BSA for 48 h was determined using LCN2 ELISA kit.  Data are 
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expressed as the mean ± SD of ten samples.  **P<0.01 comparing with BSA 
and P.g-LPS+BSA. 
 
Figure 6.  Effect of AGE-induced LCN2 from TR146 cells on IL-6 expression 
in co-cultured D-HL-60 cells.  (A) The conditioned media were collected from 
the normal culture of TR146 cells and D-HL-60 cells and analyzed by western 
blotting using an anti-LCN2 antibody.  Three medium samples were 
analyzed and a typical image is shown.  The cell lysates (20 µg protein) were 
isolated from cultured TR146 and D-HL-60 cells, and analyzed by a western 
blotting using an anti-24p3R antibody, as described in Materials and Methods.  
Two signals of 24p3R-L and -S were detected in the same samples.  Five cell 
lysate samples were analyzed and a typical image is shown.  (B) Total RNA 
was extracted from TR146 cells transfected with siLCN2 or siControl, and 
then stimulated with AGEs or BSA as described in Materials and Methods.   
RNA samples were analyzed by qRT-PCR to examine LCN2 mRNA expression 
levels.  Data are expressed as the mean ± SD of eight samples.  (C) After co-
culture with TR146 and D-HL-60 cells for 24 h, conditioned medium without 
AGEs was collected and used for LCN2 ELISA.  Data are expressed as the 
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mean ± SD of thirteen samples.  (D) Total RNA was extracted from the co-
cultured D-HL 60 cells (350x104 cell/Transwell insert) and analyzed by qRT-
PCR for IL6 mRNA.  Data are expressed as the mean ± SD of eight-thirteen 
samples.  *P<0.05, **P<0.01 comparing between BSA and AGEs in the 
siControl group, and comparing BSA and AGEs between siControl and 
siLCN2. 
 
Figure 7.  Effect of AGE-induced LCN2 from TR146 cells on the migration of 
D- HL-60 cells.  D-HL-60 cells (350x104 cells/ml) were co-cultured with 
TR146 cells transfected with siLCN2 or siControl, and treated with AGEs or 
BSA for 24 h using Transwell® plates (A: siControl-BSA, B: siControl-AGE, C: 
siLCN2-BSA, D: siLCN2-AGE).  D-HL-60 cells that migrated to the 
undersurface of the membrane of Transwell insert were fixed and stained 
with 0.2% crystal violet solution, as described in Materials and Methods.  
The migrated cells were observed using a phase-contrast microscope.  (E) 
The numbers of D-HL-60 cells that migrated to undersurface of the Transwell 
insert membranes were counted for each experimental group.  Data are 
expressed as the mean ± SD of four microscopic fields on three separated 
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membranes in each experimental group.  **P<0.01 comparing between BSA 
and AGEs in the siControl group, and comparing with BSA and AGEs 
between siControl and siLCN2.  BSA siControl: 428±28 cells/field. 
 
Figure 8.  A schematic diagram showing the proposed mechanism that AGE-
induced LCN2 expression in human oral epithelial cells and function of 
secreted LCN2.  The secreted LCN2 plays a role of inflammatory modulator 
by down-regulating IL-6 expression in neutrophils and promoting migration 




















































































































































































































































































































































































































































































































































































































































of	IL1B (A)	and	TNFA	(B).			Data	of	IL1B and	TNFA are	expressed	as	the	mean±SD of	20	and18	samples,
respectively.		**P<0.01	as	compared	between	siControl and	siLCN2	in	BSA	group	(A).	
